Search Results 851-860 of 8042 for driving with dementia
ALSENLITE: Senolytics for Alzheimer's Disease. Rochester, Minn. The purpose of this study is to measure target engagement in cerebrospinal fluid (CSF) and blood ...
Rochester, Minn. The purpose of this study is to investigate whether recent, groundbreaking discoveries about key pathophysiologic processes that drive chronic ...
Your health care team tells you when you can safely return to daily life activities such as driving, exercising, going to work or being sexually active. You ...
Clinical/cognitive, imaging, biomarker, and genetic characteristics will be assessed across three cohorts: (1) early onset Alzheimer's Disease (EOAD) ...
Research shows as many as 1 in 5 people age 65 and older will develop mild cognitive impairment. Many of those will progress to Alzheimer's disease. But new ...
The purpose of this study is to determine when patients have returned to driving ... A Study of the Risk of Risk of Dementia ... This project is focused on ...
The American Diabetes Association recommends testing blood sugar levels before meals and snacks, before bed, before exercising or driving, and whenever you ...
Alzheimer's disease is a progressive neurologic disorder that causes memory loss and other cognitive decline due to brain cell degeneration.
There is evidence that neurodegenerative changes precede clinical symptoms in Alzheimer's disease by two decades (Villemagne et al, 2013). Early detection is ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Give by Dec. 3 to double your impact 2X.